Jane Street reports 6.3% stake in Core Scientific
Core Scientific, Inc. received an amended Schedule 13G report from Jane Street entities regarding holdings of its common stock, par value $0.00001 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Core Scientific, Inc. received an amended Schedule 13G report from Jane Street entities regarding holdings of its common stock, par value $0.00001 per share. As of June 30, 2026, Jane Street Group, LLC reported beneficial ownership of 20,125,585 Core Scientific shares, representing 6.3% of the outstanding common stock.
All reported shares are held with shared voting and shared dispositive power, and no shares are held with sole voting or dispositive power. Within the group, Jane Street Capital, LLC reported 18,771,563 shares (5.9% of the class), Jane Street Global Trading, LLC reported 1,354,018 shares (0.4%), and Jane Street Singapore Pte. Ltd. reported 4 shares. Jane Street Group, LLC files as the parent holding company for these subsidiaries.
Key Figures
Key Terms
beneficially owned financial
parent holding company financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Core Scientific (CORZ) does Jane Street report in this Schedule 13G/A?
How much voting power over Core Scientific (CORZ) stock does Jane Street have?
What type of filing is this for Core Scientific (CORZ) and what does it indicate?
Who signed the Core Scientific (CORZ) Schedule 13G/A on behalf of Jane Street?
What class of Core Scientific (CORZ) securities is covered in this Jane Street filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.